Lisata Therapeutics Stock Investor Sentiment

LSTA Stock  USD 2.58  0.07  2.64%   
About 61% of Lisata Therapeutics' investor base is looking to short. The analysis of the overall investor sentiment regarding Lisata Therapeutics suggests that many traders are alarmed. The current market sentiment, together with Lisata Therapeutics' historical and current headlines, can help investors time the market. In addition, many technical investors use Lisata Therapeutics stock news signals to limit their universe of possible portfolio assets.
  
over three months ago at finance.yahoo.com         
Is There Now An Opportunity In Celebrus Technologies plc?
Yahoo News
over three months ago at finance.yahoo.com         
Moderate and Severe Chronic Kidney Disease Therapeutics Report 2024 Comprehensive Insights about 50 ...
Yahoo News
over three months ago at insidermonkey.com         
Lisata Therapeutics, Inc. Q2 2024 Earnings Call Transcript
insidermonkey News
over three months ago at gurufocus.com         
Lisata Therapeutics Inc Q2 2024 Earnings Call Transcript Highlights Significant Expense ...
Gurufocus Stories at Macroaxis
over three months ago at investorplace.com         
LSTA Stock Earnings Lisata Therapeutics Beats EPS for Q2 2024
sbwire news
over three months ago at finance.yahoo.com         
Lisata Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update
Yahoo News
over three months ago at finance.yahoo.com         
Actio Biosciences Receives Orphan Drug and Rare Pediatric Disease Designations for ABS-0871 for the ...
Yahoo News
over three months ago at finance.yahoo.com         
Logix Biosciences, Inc. Announces Appointment of Amy Broidrick to Board of Directors
Yahoo News
over three months ago at benzinga.com         
Lisata Therapeutics to Report Second Quarter 2024 Financial Results and Provide a Business Update on...
benzinga news
over three months ago at finance.yahoo.com         
BD Q3 Earnings Surpass Estimates, Margins Expand
Yahoo News
over three months ago at businesswire.com         
Terremoto Biosciences Appoints Charles Baum, M.D., Ph.D., as Chief Executive Officer
businesswire News
over three months ago at benzinga.com         
Quest Diagnostics Haystack Oncology Forges New MRD Deal
benzinga news
over three months ago at seekingalpha.com         
Lisata to use Haystack technology to evaluate pancreatic cancer asset certepetide
seekingalpha News
over three months ago at finance.yahoo.com         
Haystack Oncology, Lisata Therapeutics Collaborate on Pancreatic Cancer Therapy
Yahoo News
over three months ago at benzinga.com         
EXCLUSIVE Haystack Oncology Inks Research Collaboration With Lisata Therapeutics To Use Haystack MRD...
benzinga news
Far too much social signal, news, headlines, and media speculation about Lisata Therapeutics that are available to investors today. That information is available publicly through Lisata media outlets and privately through word of mouth or via Lisata internal channels. However, regardless of the origin, that massive amount of Lisata data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Lisata Therapeutics news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Lisata Therapeutics relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Lisata Therapeutics' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Lisata Therapeutics alpha.

Lisata Therapeutics Performance against Dow Jones

 Price Growth (%)  
       Timeline  

Complementary Tools for Lisata Stock analysis

When running Lisata Therapeutics' price analysis, check to measure Lisata Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lisata Therapeutics is operating at the current time. Most of Lisata Therapeutics' value examination focuses on studying past and present price action to predict the probability of Lisata Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lisata Therapeutics' price. Additionally, you may evaluate how the addition of Lisata Therapeutics to your portfolios can decrease your overall portfolio volatility.
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Bonds Directory
Find actively traded corporate debentures issued by US companies
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
CEOs Directory
Screen CEOs from public companies around the world
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites